Tag: Aurobindo Pharma
USFDA issues Form 483 with 10 observations to Aurobindo Pharma
Aurobindo Pharma announced that the United States Food and Drug Administration (USFDA) has issued Form 483 with 10 observations after the inspection...
USFDA gives EIR to Aurobindo Pharma for its AP facility
New Delhi: Aurobindo Pharma Ltd. said it has received an Establishment Inspection Report (EIR) from the US health regulator for its manufacturing facility at Pydibhimavaram in...
Drug recall: These drugs recalled by Aurobindo for this reason
Aurobindo Pharma units are recalling different products in the US market for manufacturing lapses, as per the US health regulator.
Drug recall: These products recalled by Dr Reddy’s, Cipla, and Aurobindo
Drugs recall
Leading drug firms like Dr. Reddy's Laboratories, Cipla, and Aurobindo Pharma are recalling different products in the US market for...
USFDA issues Form 483 for 3 observations to Aurobindo Pharma
Aurobindo Pharma said the US health regulator has issued Form 483 with three observations after inspecting its manufacturing facility at Pydibhimavaram in...
USFDA gives nod for Triamcinolone Acetonide injectable suspension
New Delhi: Aurobindo Pharma Ltd on Wednesday said its arm, Eugia Pharma Specialities Ltd, has received final approval from the US health regulator to manufacture and...
USFDA completes inspection of Aurobindo Pharma with no remaining deficiencies
The pre-approval inspection of Aurobindo Pharma was carried out from 8 February 2022 to 15 February 2022. On completion of the inspection,...
USFDA gives nod to these companies for Bortezomib for injection
Zudus
Zydus Lifesciences has received final approval from the US Food and Drug Administration (USFDA) to market Bortezomib...
USFDA issues warning letter to Aurobindo Pharma for manufacturing lapses...
New Delhi: The US Food and Drug Administration (USFDA) has issued a warning letter to Aurobindo Pharma for violating current good manufacturing practice norms...
USFDA gives warning letter to Aurobindo Pharma for API facility
Aurobindo Pharma yesterday said it has received a warning letter from the US health regulator for its Hyderabad-based Unit I, an Active...
Aurobindo Pharma, MSN Labs seek DCGI nod for Phase-III trials of...
Two Indian pharmaceutical companies have sought permission from India’s drug regulator to continue phase III trials on antiviral drug molnupiravir in mild C-19 patient....
Drug recall: Glenmark, Aurobindo recall multiple products
Glenmark Pharmaceuticals and Aurobindo Pharma are recalling multiple products in the US market due to various reasons like deviation from standard manufacturing protocols and presence of foreign...
Aurobindo Pharma gets Indian patent for this Antiviral Drug
The Indian Patent Office has granted patent to Aurobindo Pharma for its process for the preparation of its antiviral drug valacyclovir, which...
Aurobindo Pharma gets USFDA nod for cancer treatment drug
New Delhi: Drug firm Aurobindo Pharma on Friday said its arm Eugia Pharma Specialities has received approval from the US health regulator for Cyclophosphamide injection, used in...
PLI Scheme: Govt re-invites applications to Mfr Erythromycin
The Department of Pharmaceuticals (DoP) has re-invited applications from eligible applicants to manufacture fermentation based key starting material/drug intermediate erythromycin thiocyanate under...
Pharma Companies recall these drugs in US
Sun Pharma, Dr Reddy’s Laboratories, Aurobindo Pharma and Jubilant Pharma are recalling products in the US market for various reasons.
Aurobindo Pharma gets USFDA nod for generic Droxidopa capsules
New Delhi: Drug major Aurobindo Pharma on Friday said it has received final approval from the US health regulator to manufacture and market Droxidopa capsules, used...
More Pharma firms for PLI scheme to boost bulk drug output:...
The government plans to select more pharmaceutical firms for its production-linked incentive (PLI) scheme for 37 bulk drugs by the end of...
Aurobindo Pharma to mfr COVAXX vaccine for India and UNICEF
Aurobindo Pharma Ltd said on Thursday that it will make COVAXX's C-19 vaccine candidate for India and UNICEF under a licensing deal....
Pfizer moves US court against Aurobindo, Dr Reddy’s on cancer drug
HYDERABAD: Pfizer Inc and its group companies filed a petition in a US court against Aurobindo Pharma Ltd and Dr Reddy's Laboratories alleging that the Indian drug...
Indian Pharma Cos recall various products in US market
New Delhi: Indian drug firms like Marksans Pharma, Aurobindo Pharma, Zydus and Jubilant are recalling products in the US market, as per the latest enforcement report by the...
Aurobindo Pharma gets USFDA nod for pain treatment injection
New Delhi: Drug firm Aurobindo Pharma on Thursday said it has received final approval from the US health regulator for its generic Acetaminophen injection, used...
Aurobindo Pharma acquires 100 % share of Eugia Pharma Specialities
Aurobindo Pharma has entered into a share purchase agreement today to acquire 100 per cent equity share capital of MViyeS Pharma Ventures....
USFDA issues 9 observations to Aurobindo Pharma
Hyderabad: The US Food and Drug Administration (FDA) has issued a 'Form 483' with nine observations to a manufacturing facility in the...